MYX mayne pharma group limited

Ann: 2024 Half Year Investor Presentation, page-117

  1. 1,522 Posts.
    lightbulb Created with Sketch. 269
    Yes KP although management doing a better
    job than previous imbeciles from Chairman
    down. Some of those ridiculous decisions shows
    they are capable of stupidity.
    CEO seems the goods , As far as the board is
    concerned not until they invest some reasonable
    amount of $$$ will I be convinced of their personal
    confidence in future growth and profitability of
    Mayne.
    Regarding situation with Mithra you only have to
    look at their revenue from World distribution of
    Nextellis to see they were dependent upon
    upfront licensing fees not manufacturing margins
    to sustain their growth.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.92
Change
-0.110(2.19%)
Mkt cap ! $399.7M
Open High Low Value Volume
$5.03 $5.03 $4.86 $1.730M 352.1K

Buyers (Bids)

No. Vol. Price($)
1 100 $4.88
 

Sellers (Offers)

Price($) Vol. No.
$4.93 25000 1
View Market Depth
Last trade - 16.15pm 23/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.